Skip to main content
. 2021 Oct 2;13(10):3493. doi: 10.3390/nu13103493

Table 1.

Descriptive data for patients; median (interquartile range).

Study Population (n = 9)
Age (years) 73.0 (70.0–76.0)
Gender ratio (M:F) 5:4
Height (cm) 169.0 (160.5–178.0)
Bodyweight (kg) 84.0 (73.5–91.4)
BMI 1 (kg/m2) 26.9 (25.0–32.7)
Smoking; n (%) 1 (11.1)
Alcohol; n (%) 1 (11.1)
Comorbidity; n (%)
Cardiovascular disease 7 (77.8)
Pulmonary disease 5 (55.6)
History of abdominal surgery 2 (22.2)
History of other malignancy 2 (22.2)
ASA score 2; n (%)
II 7 (77.8)
III 2 (22.2)
GFI 3; n (%)
0 1 (11.1)
I 2 (22.2)
II 1 (11.1)
III 1 (11.1)
IV 2 (22.2)
V 2 (22.2)
SNAQ 4; n (%)
0 6 (66.7)
I 2 (22.2)
V 1 (11.1)
Diagnosis; n
Malignancy 8
Liver metastasis at diagnosis 1
Premalignancy 1
Adjuvant treatment; n
Neoadjuvant chemoradiation 2
Adjuvant chemotherapy 1

1 BMI: body mass index; 2 ASA: American Society of Anesthesiologists physical status classification system; 3 GFI: Geriatric Frailty Index, 4 SNAQ: Short Nutritional Assessment Questionnaire.